Literature DB >> 27726231

Three-dimensional T1 and T2* mapping of human lung parenchyma using interleaved saturation recovery with dual echo ultrashort echo time imaging (ITSR-DUTE).

Neville D Gai1, Ashkan A Malayeri1, David A Bluemke1.   

Abstract

PURPOSE: To develop and assess a new technique for three-dimensional (3D) full lung T1 and T2* mapping using a single free breathing scan during a clinically feasible time.
MATERIALS AND METHODS: A 3D stack of dual-echo ultrashort echo time (UTE) radial acquisition interleaved with and without a WET (water suppression enhanced through T1 effects) saturation pulse was used to map T1 and T2* simultaneously in a single scan. Correction for modulation due to multiple views per segment was derived. Bloch simulations were performed to study saturation pulse excitation profile on lung tissue. Optimization of the saturation delay time (for T1 mapping) and echo time (for T2* mapping) was performed. Monte Carlo simulation was done to predict accuracy and precision of the sequence with signal-to-noise ratio of in vivo images used in the simulation. A phantom study was carried out using the 3D interleaved saturation recovery with dual echo ultrashort echo time imaging (ITSR-DUTE) sequence and reference standard inversion recovery spin echo sequence (IR-SE) to compare accuracy of the sequence. Nine healthy volunteers were imaged and mean (SD) of T1 and T2* in lung parenchyma at 3T were estimated through manually assisted segmentation. 3D lung coverage with a resolution of 2.5 × 2.5 × 6 mm3 was performed and nominal scan time was recorded for the scans. Repeatability was assessed in three of the volunteers. Regional differences in T1/T2* values were also assessed.
RESULTS: The phantom study showed accuracy of T1 values to be within 2.3% of values obtained from IR-SE. Mean T1 value in lung parenchyma was 1002 ± 82 ms while T2* was 0.85 ± 0.1 ms. Scan time was ∼10 min for volunteer scans. Mean coefficient of variation (CV) across slices was 0.057 and 0.09, respectively. Regional variation along the gravitational direction and between right and left lung were not significant (P = 0.25 and P = 0.06, respectively) for T1. T2* showed significant variation (P = 0.03) along the gravitational direction. Repeatability for three volunteers was within 0.7% for T1 and 1.9% for T2*.
CONCLUSION: 3D T1 and T2* maps of the entire lung can be obtained in a single scan of ∼10 min with a resolution of 2.5 × 2.5 × 6 mm3 . LEVEL OF EVIDENCE: 2 J. Magn. Reson. Imaging 2017;45:1097-1104. 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  ITSR-DUTE; T1 mapping; T2* mapping; lung parenchyma; three dimensional

Mesh:

Year:  2016        PMID: 27726231     DOI: 10.1002/jmri.25487

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Long T2 suppression in native lung 3-D imaging using k-space reordered inversion recovery dual-echo ultrashort echo time MRI.

Authors:  Neville D Gai; Ashkan A Malayeri; David A Bluemke
Journal:  MAGMA       Date:  2017-03-10       Impact factor: 2.310

2.  Comparison of phase-resolved functional lung (PREFUL) MRI derived perfusion and ventilation parameters at 1.5T and 3T in healthy volunteers.

Authors:  Julian Glandorf; Filip Klimeš; Andreas Voskrebenzev; Marcel Gutberlet; Lea Behrendt; Cristian Crisosto; Frank Wacker; Pierluigi Ciet; Jim M Wild; Jens Vogel-Claussen
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

3.  Conventional MRI to detect the differences between mass-like tuberculosis and lung cancer.

Authors:  Li-Ping Qi; Ke-Neng Chen; Xiaohong Joe Zhou; Lei Tang; Yu-Liang Liu; Xiao-Ting Li; Juan Wang; Ying-Shi Sun
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

4.  Three-dimensional magnetic resonance imaging ultrashort echo-time cones for assessing lung density in pediatric patients.

Authors:  Konstantinos G Zeimpekis; Julia Geiger; Florian Wiesinger; Gaspar Delso; Christian J Kellenberger
Journal:  Pediatr Radiol       Date:  2020-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.